|
US5885971A
(en)
*
|
1995-03-24 |
1999-03-23 |
The Regents Of The University Of California |
Gene therapy by secretory gland expression
|
|
US6531455B1
(en)
*
|
1995-03-24 |
2003-03-11 |
The Regents Of The University Of California |
Delivery of polynucleotides by secretory gland expression
|
|
US20020037867A1
(en)
*
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
EP0932694A2
(en)
|
1996-09-11 |
1999-08-04 |
THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Aav4 vector and uses thereof
|
|
US6797505B2
(en)
*
|
1998-05-27 |
2004-09-28 |
Cell Genesys, Inc. |
Recombinant AAV vectors for gene therapy of hemophilia A
|
|
ES2313784T3
(es)
*
|
1998-05-28 |
2009-03-01 |
The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Vector aav5 y usos del mismo.
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
US6759237B1
(en)
*
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
AU780231B2
(en)
|
1998-11-10 |
2005-03-10 |
University Of North Carolina At Chapel Hill, The |
Virus vectors and methods of making and administering the same
|
|
ATE374251T1
(de)
*
|
1999-02-19 |
2007-10-15 |
Engene Inc |
Zusammensetzungen zur gentherapie von diabetes
|
|
US8063022B1
(en)
|
1999-06-08 |
2011-11-22 |
The Children's Hospital Of Philadelphia |
Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
|
|
US6610906B1
(en)
*
|
1999-06-09 |
2003-08-26 |
The Regents Of The University Of Michigan |
Nucleotide sequences for gene regulation and methods of use thereof
|
|
US7217699B2
(en)
*
|
2000-01-03 |
2007-05-15 |
Panagenic International, Inc. |
Compositions comprising genome segments and methods of using the same
|
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
|
AU6814901A
(en)
|
2000-06-01 |
2001-12-11 |
Univ North Carolina |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
AU2001268373A1
(en)
*
|
2000-06-13 |
2001-12-24 |
The Children's Hospital Of Philadelphia |
Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
|
|
AU2002226028A1
(en)
*
|
2000-11-14 |
2002-05-27 |
Board Of Regents, Unversity Of Texas Systems |
Mutant human factor ix with an increased resistance to inhibition by heparin
|
|
US6794376B2
(en)
*
|
2000-12-06 |
2004-09-21 |
William Beaumont Hospital |
Methods and compositions for enhancing diffusion of therapeutic agents through tissue
|
|
US20020159978A1
(en)
*
|
2001-02-06 |
2002-10-31 |
James Allen |
Muscle-directed gene transfer by use of recombinant AAV-1 and AAV-6 virions
|
|
WO2003013244A1
(en)
|
2001-08-03 |
2003-02-20 |
The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Oral treatment of hemophilia
|
|
DK1567641T3
(da)
|
2001-08-24 |
2012-08-27 |
Uvic Industry Partnerships Inc |
Proaerolysin indeholdende proteaseaktiveringssekvenser og fremgangsmåder til anvendelse til behandling af prostatacancer.
|
|
US20030198620A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
US20040092008A1
(en)
*
|
2002-11-12 |
2004-05-13 |
Snyder Richard O. |
Recombinant AAV vectors for gene therapy of hemophilia A
|
|
WO2005017101A2
(en)
|
2003-05-19 |
2005-02-24 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH |
Avian adenoassociated virus (aaav) and uses thereof
|
|
PL3235827T3
(pl)
|
2003-06-19 |
2021-07-05 |
Genzyme Corporation |
Wiriony AAV o zmniejszonej immunoreaktywności i ich zastosowania
|
|
US8137960B2
(en)
|
2003-12-04 |
2012-03-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Bovine adeno-associated viral (BAAV) vector and uses thereof
|
|
US20060078542A1
(en)
*
|
2004-02-10 |
2006-04-13 |
Mah Cathryn S |
Gel-based delivery of recombinant adeno-associated virus vectors
|
|
US7722596B2
(en)
*
|
2004-02-26 |
2010-05-25 |
Osprey Medical, Inc. |
Regional cardiac tissue treatment
|
|
DK1804839T3
(da)
|
2004-09-22 |
2012-04-10 |
St Jude Childrens Res Hospital |
Forbedret ekspression af faktor ix i genterapivektorer
|
|
CA2591544A1
(en)
|
2004-12-15 |
2006-06-22 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
WO2006089340A2
(en)
*
|
2005-02-23 |
2006-08-31 |
V-Kardia Pty Ltd |
Polynucleotide delivery to cardiac tissue
|
|
US8283151B2
(en)
|
2005-04-29 |
2012-10-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
|
|
US8152786B2
(en)
*
|
2006-11-07 |
2012-04-10 |
Osprey Medical, Inc. |
Collection catheter and kit
|
|
US9050400B2
(en)
*
|
2008-08-12 |
2015-06-09 |
Osprey Medical, Inc. |
Remote sensing catheter system and methods
|
|
US20100041984A1
(en)
*
|
2008-08-12 |
2010-02-18 |
James Edward Shapland |
Impedance sensing device and catheter system
|
|
ES2634118T3
(es)
|
2009-02-11 |
2017-09-26 |
The University Of North Carolina At Chapel Hill |
Vectores de virus modificados y métodos para fabricar y utilizar los mismos
|
|
FR2952374B1
(fr)
*
|
2009-11-06 |
2012-11-16 |
Univ Claude Bernard Lyon |
Production de facteur ix recombinant dans une lignee cellulaire hepatocytaire humaine
|
|
CA2780362C
(en)
|
2009-11-09 |
2019-12-24 |
University Of Central Florida Research Foundation, Inc. |
Administration of plant expressed oral tolerance agents
|
|
WO2011071988A1
(en)
*
|
2009-12-08 |
2011-06-16 |
Health Research, Inc. |
Methods and compositions using peroxiredoxin 1 (prx1) as an adjuvant
|
|
US9295816B2
(en)
*
|
2009-12-09 |
2016-03-29 |
Osprey Medical, Inc. |
Catheter with distal and proximal ports
|
|
PT2529020T
(pt)
|
2010-01-28 |
2018-07-30 |
Childrens Hospital Philadelphia |
Plataforma de fabrico escalável para purificação de vetor viral e vetores virais assim purificados para utilização na terapia génica
|
|
WO2012051343A1
(en)
*
|
2010-10-12 |
2012-04-19 |
The Children's Hospital Of Philadelphia |
Methods and compositions for treating hemophilia b
|
|
US20140206753A1
(en)
*
|
2011-06-08 |
2014-07-24 |
Shire Human Genetic Therapies, Inc. |
Lipid nanoparticle compositions and methods for mrna delivery
|
|
EP2721151B1
(en)
|
2011-06-20 |
2017-12-06 |
Mount Sinai School Of Medicine |
Anti-tnf-therapy for the mucopolysaccharidoses and other lysosomal disorders
|
|
US9211372B2
(en)
|
2011-08-11 |
2015-12-15 |
Osprey Medical, Inc. |
Systems and methods for limb treatment
|
|
RU2705249C2
(ru)
*
|
2013-07-12 |
2019-11-06 |
Дзе Чилдрен'З Хоспитал Оф Филадельфия |
Вектор aav и анализ на нейтрализующие антитела против aav (аденоассоциированного вируса)
|
|
CA2939847C
(en)
|
2014-03-21 |
2023-09-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
ES2934848T3
(es)
*
|
2015-12-11 |
2023-02-27 |
Univ Pennsylvania |
Método de purificación escalable para AAV8
|
|
SG11201808475XA
(en)
|
2016-04-15 |
2018-10-30 |
Baxalta Inc |
Method and apparatus for providing a pharmacokinetic drug dosing regiment
|
|
US10896749B2
(en)
|
2017-01-27 |
2021-01-19 |
Shire Human Genetic Therapies, Inc. |
Drug monitoring tool
|
|
KR102386890B1
(ko)
|
2017-05-22 |
2022-04-15 |
다케다 야쿠힌 고교 가부시키가이샤 |
B형 혈우병 유전자 요법을 위한 증가된 발현을 가지는 재조합 fix 변이체를 암호화하는 바이러스 벡터
|
|
WO2019083171A2
(ko)
|
2017-10-26 |
2019-05-02 |
주식회사 큐로진생명과학 |
솔루블 vegfr-1 변이체 cdna를 함유하는 raav를 포함하는 황반변성 치료용 조성물
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
BR112021007301A2
(pt)
|
2018-10-18 |
2021-07-27 |
Intellia Therapeutics, Inc. |
composições e métodos para expressar fator ix
|